<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35230003</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>02</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1332-8166</ISSN><JournalIssue CitedMedium="Internet"><Volume>63</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Feb</Month><Day>28</Day></PubDate></JournalIssue><Title>Croatian medical journal</Title><ISOAbbreviation>Croat Med J</ISOAbbreviation></Journal><ArticleTitle>Risk factors and severity of functional impairment in long COVID: a single-center experience in Croatia.</ArticleTitle><Pagination><StartPage>27</StartPage><EndPage>35</EndPage><MedlinePgn>27-35</MedlinePgn></Pagination><Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">To determine the frequency of common symptoms in long COVID and their effect on the quality of life, and to determine the factors contributing to a more severe long COVID.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The study enrolled 266 patients who were either referred to long-COVID outpatient clinic or were inpatients undergoing rehabilitation. The data were collected between December 2020 and May 2021. We evaluated the symptoms experienced during acute and long COVID and comorbidities. Functional status was assessed with Post Covid Functional Status (PCFS).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The final sample consisted of 261 patients. After acute COVID-19 period (&gt;4 weeks), almost 80% of patients had impaired functional status. Only 21.5% reported no functional impairment (0 on PCFS scale). A higher PCFS score was associated with female sex (P&lt;0.001) and oxygen therapy requirement during acute disease (P=0.001). However, it was not associated with having a pre-existing lung disease (P=0.749). Disease severity did not pose a risk for developing a more severe long COVID.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Women were at greater risk for developing greater functional impairment in long COVID, although we have no explanation why. Malignant disease and hypertension also presented a risk factor for greater functional impairment. More studies are warranted to determine if patients with certain lung disease are more susceptible to long COVID.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bani&#x107;</LastName><ForeName>Marko</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Jankovi&#x107; Makek</LastName><ForeName>Mateja</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Samar&#x17e;ija</LastName><ForeName>Miroslav</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Mur&#x161;i&#x107;</LastName><ForeName>Davorka</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Boras</LastName><ForeName>Zagorka</ForeName><Initials>Z</Initials></Author><Author ValidYN="Y"><LastName>Trke&#x161;</LastName><ForeName>Vesna</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Bari&#x10d;evi&#x107;</LastName><ForeName>Denis</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Kor&#x161;i&#x107;</LastName><ForeName>Marta</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Basara</LastName><ForeName>Latinka</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Jalu&#x161;i&#x107; Glun&#x10d;i&#x107;</LastName><ForeName>Tajana</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Vuki&#x107; Dugac</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Andrea Vuki&#x107; Dugac, Clinic for respiratory diseases "Jordanovac", University Hospital Centre Zagreb, Jordanovac 104, 10 000 Zagreb, Croatia, adugac71@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Croatia</Country><MedlineTA>Croat Med J</MedlineTA><NlmUniqueID>9424324</NlmUniqueID><ISSNLinking>0353-9504</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017523" MajorTopicYN="N" Type="Geographic">Croatia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>1</Day><Hour>8</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>2</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35230003</ArticleId><ArticleId IdType="pmc">PMC8895334</ArticleId><ArticleId IdType="doi">10.3325/cmj.2022.27</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Karadag E. Increase in COVID-19 cases and case-fatality and case-recovery rates in Europe: A cross-temporal meta-analysis. J Med Virol. 2020;92:1511&#x2013;7. doi: 10.1002/jmv.26035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26035</ArticleId><ArticleId IdType="pmc">PMC7280723</ArticleId><ArticleId IdType="pubmed">32437052</ArticleId></ArticleIdList></Reference><Reference><Citation>Hozhabri H, Piceci Sparascio F, Sohrabi H, Mousavifar L, Roy R, Scribano D, et al. The global emergency of novel coronavirus (SARS-CoV-2): An update of the current status and forecasting. Int J Environ Res Public Health. 2020;17:5648. doi: 10.3390/ijerph17165648.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17165648</ArticleId><ArticleId IdType="pmc">PMC7459861</ArticleId><ArticleId IdType="pubmed">32764417</ArticleId></ArticleIdList></Reference><Reference><Citation>Goshua G, Pine AB, Meizlish ML, Chang C-H, Zhang H, Bahel P, et al. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol. 2020;7:e575&#x2013;82. doi: 10.1016/S2352-3026(20)30216-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(20)30216-7</ArticleId><ArticleId IdType="pmc">PMC7326446</ArticleId><ArticleId IdType="pubmed">32619411</ArticleId></ArticleIdList></Reference><Reference><Citation>Lab&#xf2; N, Ohnuki H, Tosato G. Vasculopathy and coagulopathy associated with SARS-CoV-2 infection. Cells. 2020;9:1583. doi: 10.3390/cells9071583.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9071583</ArticleId><ArticleId IdType="pmc">PMC7408139</ArticleId><ArticleId IdType="pubmed">32629875</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhakal BP, Sweitzer NK, Indik JH, Acharya D, William P. SARS-CoV-2 Infection and cardiovascular disease: COVID-19 heart. Heart Lung Circ. 2020;29:973&#x2013;87. doi: 10.1016/j.hlc.2020.05.101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlc.2020.05.101</ArticleId><ArticleId IdType="pmc">PMC7274628</ArticleId><ArticleId IdType="pubmed">32601020</ArticleId></ArticleIdList></Reference><Reference><Citation>Habashi NM, Camporota L, Gatto LA, Nieman G. Functional pathophysiology of SARS-CoV-2-induced acute lung injury and clinical implications. J Appl Physiol. 2021;130:877&#x2013;91. doi: 10.1152/japplphysiol.00742.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00742.2020</ArticleId><ArticleId IdType="pmc">PMC7984238</ArticleId><ArticleId IdType="pubmed">33444117</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B, Huang S, Yin L. The cytokine storm and COVID-19. J Med Virol. 2021;93:250&#x2013;6. doi: 10.1002/jmv.26232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26232</ArticleId><ArticleId IdType="pmc">PMC7361342</ArticleId><ArticleId IdType="pubmed">32592501</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;32. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomar BS, Singh M, Nathiya D, Sharma A, Sharma E, Bareth H, et al. Prevalence of symptoms in patients discharged from COVID care facility of NIMS hospital: Is RT PCR negativity truly reflecting recovery? A single-centre observational study. Int J Gen Med. 2021;14:1069&#x2013;78. doi: 10.2147/IJGM.S295499.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S295499</ArticleId><ArticleId IdType="pmc">PMC8006813</ArticleId><ArticleId IdType="pubmed">33790636</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Barnett J, Brill SE, Brown JS, Denneny EK, Hare SS, et al. &#x2018;Long-COVID&#x2019;: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76:396&#x2013;8. doi: 10.1136/thoraxjnl-2020-215818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins V, Sohaei D, Diamandis EP, Prassas I. COVID-19: from an acute to chronic disease? Potential long-term health consequences. Crit Rev Clin Lab Sci. 2021;58:297&#x2013;310. doi: 10.1080/10408363.2020.1860895.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408363.2020.1860895</ArticleId><ArticleId IdType="pubmed">33347790</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-De-Las-Pen&#xe3;s C, Palacios-Cen&#xe3; D, G&#xf3;mez-Mayordomo V, Palacios-Cen&#xe3; M, Rodr&#xed;guez-Jim&#xe9;nez J, De-La-Llave-Rinc&#xf3;n AI, et al. Fatigue and dyspnoea as main persistent post-covid-19 symptoms in previously hospitalized patients: related functional limitations and disability. Respiration. 2021:1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8678253</ArticleId><ArticleId IdType="pubmed">34569550</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumann M. COVID-19 and mental health in children and adolescents: a diagnostic panel to map psycho-social consequences in the pandemic context. Discov Ment Heal. 2021;1:2. doi: 10.1007/s44192-021-00002-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s44192-021-00002-x</ArticleId><ArticleId IdType="pmc">PMC8544185</ArticleId><ArticleId IdType="pubmed">35174361</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Auckl) 2021;53:737&#x2013;54. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth NC, Kim A, Vitkovski T, Xia J, Ramirez G, Bernstein D, et al. Post-COVID-19 cholangiopathy: a novel entity. Am J Gastroenterol. 2021;116:1077&#x2013;82. doi: 10.14309/ajg.0000000000001154.</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/ajg.0000000000001154</ArticleId><ArticleId IdType="pubmed">33464757</ArticleId></ArticleIdList></Reference><Reference><Citation>Rando HM, Bennett TD, Byrd JB, Bramante C, Callahan TJ, Chute CG, et al. Challenges in defining Long COVID: Striking differences across literature, Electronic Health Records, and patient-reported information. medRxiv. 2021. 10.1101/2021.03.20.21253896</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.20.21253896</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 rapid guideline: managing the long-term effects of COVID-19. National Institute for Health and Care Exellence, Available from: https://www.nice.org.uk/guidance/ng188. Accessed: November 15, 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid&#x2014;mechanisms, risk factors, and management. BMJ. 2021;374</Citation><ArticleIdList><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok FA, Boon GJAM, Barco S, Endres M, Geelhoed JJM, Knauss S, et al. The post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19. Eur Respir J. 2020;56:2001494. doi: 10.1183/13993003.01494-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01494-2020</ArticleId><ArticleId IdType="pmc">PMC7236834</ArticleId><ArticleId IdType="pubmed">32398306</ArticleId></ArticleIdList></Reference><Reference><Citation>Machado FVC, Meys R, Delbressine JM, Vaes AW, Go&#xeb;rtz YMJ, van Herck M, et al. Construct validity of the Post-COVID-19 Functional Status Scale in adult subjects with COVID-19. Health Qual Life Outcomes. 2021;19:40. doi: 10.1186/s12955-021-01691-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-021-01691-2</ArticleId><ArticleId IdType="pmc">PMC7856622</ArticleId><ArticleId IdType="pubmed">33536042</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito AJ, Menon AA, Ghosh AJ, Putman RK, Fredenburgh LE, El-Chemaly SY, et al. Increased odds of death for patients with interstitial lung disease and COVID-19: A case&#x2013;control study. Am J Respir Crit Care Med. 2020;202:1710&#x2013;3. doi: 10.1164/rccm.202006-2441LE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202006-2441LE</ArticleId><ArticleId IdType="pmc">PMC7737588</ArticleId><ArticleId IdType="pubmed">32897754</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin DMG, Criner GJ, Papi A, Singh D, Anzueto A, Martinez FJ, et al. Global Initiative for the diagnosis, management, and prevention of chronic obstructive lung disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2021;203:24&#x2013;36. doi: 10.1164/rccm.202009-3533SO.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202009-3533SO</ArticleId><ArticleId IdType="pmc">PMC7781116</ArticleId><ArticleId IdType="pubmed">33146552</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieberman-Cribbin W, Rapp J, Alpert N, Tuminello S, Taioli E. The Impact of asthma on mortality in patients with COVID-19. Chest. 2020;158:2290&#x2013;1. doi: 10.1016/j.chest.2020.05.575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2020.05.575</ArticleId><ArticleId IdType="pmc">PMC7832045</ArticleId><ArticleId IdType="pubmed">32522556</ArticleId></ArticleIdList></Reference><Reference><Citation>Lovinsky-Desir S, Deshpande DR, De A, Murray L, Stingone JA, Chan A, et al. Asthma among hospitalized patients with COVID-19 and related outcomes. J Allergy Clin Immunol. 2020;146:1027&#x2013;1034.e4. doi: 10.1016/j.jaci.2020.07.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.07.026</ArticleId><ArticleId IdType="pmc">PMC7409831</ArticleId><ArticleId IdType="pubmed">32771560</ArticleId></ArticleIdList></Reference><Reference><Citation>RStudio Team. RStudio: Integrated Development Environment for R. Boston, MA; 2015.</Citation></Reference><Reference><Citation>Sevin CM, Bloom SL, Jackson JC, Wang L, Ely EW, Stollings JL. Comprehensive care of ICU survivors: Development and implementation of an ICU recovery center. J Crit Care. 2018;46:141&#x2013;8. doi: 10.1016/j.jcrc.2018.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2018.02.011</ArticleId><ArticleId IdType="pmc">PMC6020044</ArticleId><ArticleId IdType="pubmed">29929705</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID. Nat Med. 2021;27:626&#x2013;31. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19. Kretzschmar MEE, editor. PLOS Med. 2021 Sep 28;18(9):e1003773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucijani&#x107; M, Piska&#x10d; &#x17d;ivkovi&#x107; N, Bu&#x161;i&#x107; N, Jurin I, Ati&#x107; A, Andrilovi&#x107; A, et al. Dob, spol i komorbiditeti i njihov odraz na prognozu pacijenata s bole&#x161;&#x107;u COVID-19 &#x2013; iskustva tercijarnog centra / Age, sex and comorbidities and their associations with prognosis of covid-19 patients. Lijec Vjesn. 2021;143(Supp 4):3&#x2013;4.</Citation></Reference><Reference><Citation>Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol. 2021;93:1013&#x2013;22. doi: 10.1002/jmv.26368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26368</ArticleId><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobsen GD, Jacobsen KH. Statewide COVID-19 Stay-at-home orders and population mobility in the United States. World Med Health Policy. 2020;12:347&#x2013;56. doi: 10.1002/wmh3.350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wmh3.350</ArticleId><ArticleId IdType="pmc">PMC7405141</ArticleId><ArticleId IdType="pubmed">32837774</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>